Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2022 edition): An interpretation
- VernacularTitle:《中华医学会肺癌临床诊疗指南（2022版）》解读
- Author:
Runbo ZHONG
1
;
Yiyang WANG
2
;
Baohui HAN
1
;
Wentao FANG
2
Author Information
1. Department of Respiratory Medicine, Shanghai Chest Hospital, Shanghai, 200030, P. R. China
2. Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai, 200030, P. R. China
- Publication Type:Journal Article
- Keywords:
Lung cancer;
diagnosis;
treatment;
guideline;
interpretation
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(11):1402-1406
- CountryChina
- Language:Chinese
-
Abstract:
Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2022 edition) has been published this year. The 2022 edition has been updated in the aspects of lung cancer screening, pathology, standards of thoracic surgery, treatment of metastatic lung cancer. In this study, we tried to introduce those updated aspects in the guideline of 2022 edition.
